by In2Pharma | Mar 28, 2023 | News
Belgium As from the start of 2023, a new system for funding market surveillance of medical devices by FAMHP applies. Unlike before, this will no longer be limited to the sale of medical devices to retailers and end users. All actors that carry out an activity...
by In2Pharma | Mar 20, 2023 | News
Belgium The FAMHP would like to remind the pharmaceutical industry regarding the following topics: Pictograms related to the environment and recycling (e.g. green dot pictogram) do not comply with art.56§1 of the Royal Decree on medicines. The current guideline...
by In2Pharma | Jul 5, 2022 | News
Belgium On 4th of July 2022, the FAMHP launches the Medicinal Product Management database, a new internal database for medicinal products. Due to the launch of the new database, existing databases will temporarily not be updated. As from 22nd June data will be...
by In2Pharma | Feb 25, 2022 | News
Belgium On 03.02.2022, the Federal Parliament approved a law that adjusts the financing of the Federal Agency for Medicines and Health Products (FAMHP). This has been published in the Belgian Official Journal and will come into force soon. The law introduces new taxes...
by In2Pharma | May 5, 2021 | News
Belgium FarmaStatus is the online application that collects information about the availability of medicines in Belgium. The application shows when medicines are temporarily unavailable, when the commercialization was temporarily or permanently stopped and when...
